Vol 17 (2020)

Online first articles

Table of Contents


Radiotherapy in combination with systemic therapies for brain metastases: current status and progress PDF
Lei Liu, et al. 1-13
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges PDF
Yi Ba, et al. 1-14
Evolving insights: How DNA repair pathways impact cancer evolution PDF
Jiadong Zhou, et al. 1-22
Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects PDF
Armel H. Nwabo Kamdje, et al. 1-14
Adaptive response of resistant cancer cells to chemotherapy PDF
Yi-Jye Chern, et al. 1-22

Original Article

Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines PDF
Natalia Vargas-Rondón, et al. 1-22
Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer PDF
Jing Zhao, et al. 1-13
The IL-33/ST2 axis affects tumor growth by regulating mitophagy in macrophages and reprogramming their polarization PDF
Huadan Xu, et al. 1-13
The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer PDF
Yue Fan, et al. 1-19
A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer PDF
Qiang Ruan, et al. 1-10
The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency PDF
Yayun Gu, et al. 1-14
The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics PDF
Xiaotian Shen, et al. 1-16
Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma PDF
Ting Han, et al. 1-17